
- Volume 0 0
TIAs: WHAT TO DO WHEN ASPIRIN IS NOT ENOUGH
Patients who experience transient ischemic attacks (TIAs) are at high risk for stroke and need preventive therapy. Aspirin is commonly used to reduce the risk of stroke in these patients. Some patients, however, may continue to experience TIAs while on aspirin therapy. Data regarding the efficacy of other antiplatelet therapies such as dipyridamole, ticlopidine, or clopidogrel in combination with aspirin are limited.
The American Heart Association recognizes the lack of evidence in this area. It recommends therapy be individualized for each patient to receive either the combination of extended-release dipyridamole and aspirin or clopidogrel 75 mg daily for secondary prevention. Clopidogrel is recommended over ticlopidine because it has a better safety profile.
Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.
Articles in this issue
about 19 years ago
Equation for Success: Diabetes Medication, Diet, and Exerciseabout 19 years ago
Rx Product Newsabout 19 years ago
OTC Product Newsabout 19 years ago
can you READ these Rxs?about 19 years ago
Juvenile Anabolic Steroid Abuseabout 19 years ago
Compounding Hotlineabout 19 years ago
RESPy AWARD: A Role Model for Pharmacy Studentsabout 19 years ago
Ouch! Time for Flu Shotsabout 19 years ago
Supreme Court Declines to Review Generic Marketing PactsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.